Evidence map›Paper›PMID 37330661›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Disruption of the Clock Component Bmal1 in Mice Promotes Cancer Metastasis through the PAI-1-TGF-β-myoCAF-Dependent Mechanism.

Jieyu Wu, Xu Jing, Qiqiao Du, Xiaoting Sun, Kristian Holgersson, Juan Gao, Xingkang He, Kayoko Hosaka, Chen Zhao, Wei Tao and 4 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. The CLOCK-BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targeting.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Metastasis in biological time.Frontiers in cell and developmental biology · 2026
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Circadian clock and cancer.Military Medical Research · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 3 countries.

Jieyu WuDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 65, Sweden.ORCID 0000-0002-7063-6990
Xu JingDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 65, Sweden.
Qiqiao DuDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 65, Sweden.
Xiaoting SunOujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vison and Brain Health), School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325035, P. R. China.
Kristian HolgerssonLoma Linda University, Loma Linda, CA, 92350, USA.
Juan GaoDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 65, Sweden.
Xingkang HeDepartment of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University Medical School, Hangzhou, 310016, P. R. China.
Kayoko HosakaDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 65, Sweden.
Chen ZhaoEye Institute, Eye and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, 200433, P. R. China.
Wei TaoCenter for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Garret A FitzGeraldInstitute for Translational Medicine and Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104-5158, USA.
Yunlong YangDepartment of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, P. R. China.
Lasse D JensenDivision of Cardiovascular Medicine, Department of Medical and Health Sciences, Linkoping University, Linkoping, 581 83, Sweden.
Yihai CaoDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 65, Sweden.ORCID 0000-0003-1308-0065
Karolinska Institutet · SESun Yat-sen University · CNBrigham and Women's Hospital · USEye & ENT Hospital of Fudan University · CNLinköping University · SELoma Linda University · USShanghai Medical College of Fudan University · CNSir Run Run Shaw Hospital · CNTranslational Therapeutics (United States) · USWenzhou Medical University · CN

Funding

European Research Council 250021
6 · The paper itself

Abstract

The circadian clock in animals and humans plays crucial roles in multiple physiological processes. Disruption of circadian homeostasis causes detrimental effects. Here, it is demonstrated that the disruption of the circadian rhythm by genetic deletion of mouse brain and muscle ARNT-like 1 (Bmal1) gene, coding for the key clock transcription factor, augments an exacerbated fibrotic phenotype in various tumors. Accretion of cancer-associated fibroblasts (CAFs), especially the alpha smooth muscle actin positive myoCAFs, accelerates tumor growth rates and metastatic potentials. Mechanistically, deletion of Bmal1 abrogates expression of its transcriptionally targeted plasminogen activator inhibitor-1 (PAI-1). Consequently, decreased levels of PAI-1 in the tumor microenvironment instigate plasmin activation through upregulation of tissue plasminogen activator and urokinase plasminogen activator. The activated plasmin converts latent TGF-β into its activated form, which potently induces tumor fibrosis and the transition of CAFs into myoCAFs, the latter promoting cancer metastasis. Pharmacological inhibition of the TGF-β signaling largely ablates the metastatic potentials of colorectal cancer, pancreatic ductal adenocarcinoma, and hepatocellular carcinoma. Together, these data provide novel mechanistic insights into disruption of the circadian clock in tumor growth and metastasis. It is reasonably speculated that normalization of the circadian rhythm in patients provides a novel paradigm for cancer therapy.

Indexed as

Liver NeoplasmsTransforming Growth Factor betaAnimalsBrainFibrinolysinHumansMiceMusclesPlasminogen Activator Inhibitor 1Tissue Plasminogen ActivatorTumor MicroenvironmentFibrinolysinPlasminogen Activator Inhibitor 1Tissue Plasminogen ActivatorTransforming Growth Factor betabrain and muscle ARNT-like 1cancercircadian clockfibroblastsmetastasis

Identifiers

PMID37330661
PMCPMC10460897
OpenAlexW4381093881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.